Siemens Healthineers Will Become Healthineers Starting in 2027
Siemens Healthineers to Adopt New Name by 2027 Amid Separation from Siemens Group
Siemens Healthineers has announced plans to adopt the name "Healthineers" starting in 2027 as part of its separation from the Siemens Group. This move, which is still subject to shareholder approval, aims to allow both companies to pursue their respective strategies independently. In Morocco, the branch assures that this change will not affect its support for healthcare professionals.
The medical technology specialist Siemens Healthineers is poised to take a significant step in its development. From 2027 onward, the company plans to drop the Siemens Healthineers name in favor of Healthineers, following its anticipated separation from parent company Siemens AG.
This evolution, announced in a statement issued on November 9, 2026, in Casablanca, is part of a spin-off process that requires approval from shareholders of both groups. The transition to the new identity is expected to unfold over a three-year period.
A Separation to Enhance Autonomy for Both Groups
The reorganization aims to enable Siemens and Siemens Healthineers to focus on their strategic areas of expertise. Siemens plans to strengthen its position in industrial technologies and artificial intelligence by developing solutions that integrate digital and physical environments.
Meanwhile, Healthineers will continue to develop as an independent company specializing in medical technologies, equipment, services, and solutions aimed at the healthcare sector.
The proposed spin-off is scheduled to take place in 2027. Shareholders of Siemens AG and Siemens Healthineers AG will be called to vote on the matter during their respective general meetings planned for February. Additionally, the name change must also receive the approval of Siemens Healthineers shareholders.
The legal separation and deconsolidation of the company from the Siemens Group will subsequently depend on the official registration of the spin-off with the German commercial register, marking a crucial step before the gradual rollout of the new brand.
A Gradual Transition Over Three Years
The identity change will not occur immediately across all of the group’s activities. A transitional period of three years will accompany the transformation, particularly aimed at modifying the names of various legal entities and re-registering related products.
This timeframe is intended to allow the company to maintain continuity in its operations while preparing to embrace its new commercial and institutional identity.
According to Roland Busch, CEO of Siemens AG, this separation represents the culmination of a process that has been in motion for several years. He believes that Siemens Healthineers now has a sufficiently strong position in the global market to pursue growth under an independent identity.
Busch also notes that this move will enable Siemens to reinforce its specialization in industrial technologies and artificial intelligence, two critical components of its growth strategy.
Bernd Montag, CEO of Siemens Healthineers AG, emphasizes the continuity between the company’s legacy and its future ambitions. While the Siemens name remains tied to its origins, Healthineers is set to fully embody its identity as a specialist in medical technologies and health innovation.
In Morocco, the Subsidiary Promises Continuity in Commitments
In Morocco, this reorganization is not expected to lead to any changes in the commitments announced by the company to healthcare professionals. Gero Peters, General Manager of Siemens Healthineers Morocco, affirms that the group will continue to support medical institutions and professionals in their technological needs.
He reiterates the company’s commitment to contributing to the modernization of the Moroccan healthcare system through its equipment, innovative solutions, and expertise. According to Peters, improving medical services and patient care remains a top priority for the subsidiary.
This continuity is crucial as healthcare institutions pursue modernization efforts and adapt to evolving medical technology needs.
A Global Player Present in Over 180 Countries
Siemens Healthineers operates in more than 180 countries and has direct operations in over 70 of them. Its activities span several strategic areas, including medical imaging, diagnostics, cancer therapies, and minimally invasive therapeutic interventions.
The group also develops digital applications and solutions integrating artificial intelligence to support the evolution of medical practices.
During its fiscal year 2025, which ended on September 30 of that year, the company generated approximately €23.4 billion in revenue and employed nearly 74,000 people worldwide.
Listed on the Frankfurt Stock Exchange under the symbol SHL, Siemens Healthineers is embarking on a new chapter in its history. While the timeline for the separation remains contingent upon regulatory and shareholder approvals, the transition to the Healthineers brand is expected to affirm its status as an independent player in the global medical technology market.
